Literature DB >> 34288966

Coronary artery calcification on low-dose chest CT is an early predictor of severe progression of COVID-19-A multi-center, multi-vendor study.

Philipp Fervers1, Jonathan Kottlors1, Nils Große Hokamp1, Johannes Bremm1, David Maintz1, Stephanie Tritt2, Orkhan Safarov2, Thorsten Persigehl1, Nils Vollmar3, Paul Martin Bansmann3, Nuran Abdullayev1.   

Abstract

PURPOSE: Cardiovascular comorbidity anticipates severe progression of COVID-19 and becomes evident by coronary artery calcification (CAC) on low-dose chest computed tomography (LDCT). The purpose of this study was to predict a patient's obligation of intensive care treatment by evaluating the coronary calcium burden on the initial diagnostic LDCT.
METHODS: Eighty-nine consecutive patients with parallel LDCT and positive RT-PCR for SARS-CoV-2 were included from three centers. The primary endpoint was admission to ICU, tracheal intubation, or death in the 22-day follow-up period. CAC burden was represented by the Agatston score. Multivariate logistic regression was modeled for prediction of the primary endpoint by the independent variables "Agatston score > 0", as well as the CT lung involvement score, patient sex, age, clinical predictors of severe COVID-19 progression (history of hypertension, diabetes, prior cardiovascular event, active smoking, or hyperlipidemia), and laboratory parameters (creatinine, C-reactive protein, leucocyte, as well as thrombocyte counts, relative lymphocyte count, d-dimer, and lactate dehydrogenase levels).
RESULTS: After excluding multicollinearity, "Agatston score >0" was an independent regressor within multivariate analysis for prediction of the primary endpoint (p<0.01). Further independent regressors were creatinine (p = 0.02) and leucocyte count (p = 0.04). The Agatston score was significantly higher for COVID-19 cases which completed the primary endpoint (64.2 [interquartile range 1.7-409.4] vs. 0 [interquartile range 0-0]).
CONCLUSION: CAC scoring on LDCT might help to predict future obligation of intensive care treatment at the day of patient admission to the hospital.

Entities:  

Mesh:

Year:  2021        PMID: 34288966     DOI: 10.1371/journal.pone.0255045

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  29 in total

1.  G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences.

Authors:  Franz Faul; Edgar Erdfelder; Albert-Georg Lang; Axel Buchner
Journal:  Behav Res Methods       Date:  2007-05

2.  Coronary calcium screening using low-dose lung cancer screening: effectiveness of MDCT with retrospective reconstruction.

Authors:  Sung Mok Kim; Myung Jin Chung; Kyung Soo Lee; Yeon Hyun Choe; Chin A Yi; Bong-Keun Choe
Journal:  AJR Am J Roentgenol       Date:  2008-04       Impact factor: 3.959

3.  Comparative analysis of high-sensitivity cardiac troponin I and T for their association with coronary computed tomography-assessed calcium scoring represented by the Agatston score.

Authors:  Jonas Rusnak; Michael Behnes; Thomas Henzler; Nadine Reckord; Nils Vogler; Mathias Meyer; Ursula Hoffmann; Michele Natale; Julia Hoffmann; Sonja Hamed; Kathrin Weidner; Siegfried Lang; Agnibh Mukherji; Holger Haubenreisser; Stefan O Schoenberg; Martin Borggrefe; Thomas Bertsch; Ibrahim Akin
Journal:  Eur J Med Res       Date:  2017-11-16       Impact factor: 2.175

Review 4.  Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China.

Authors:  Bo Li; Jing Yang; Faming Zhao; Lili Zhi; Xiqian Wang; Lin Liu; Zhaohui Bi; Yunhe Zhao
Journal:  Clin Res Cardiol       Date:  2020-03-11       Impact factor: 6.138

5.  COVID-19: a simple statistical model for predicting intensive care unit load in exponential phases of the disease.

Authors:  Matthias Ritter; Derek V M Ott; Friedemann Paul; John-Dylan Haynes; Kerstin Ritter
Journal:  Sci Rep       Date:  2021-03-03       Impact factor: 4.379

6.  Coronary and total thoracic calcium scores predict mortality and provides pathophysiologic insights in COVID-19 patients.

Authors:  Francesco Giannini; Marco Toselli; Anna Palmisano; Alberto Cereda; Davide Vignale; Riccardo Leone; Valeria Nicoletti; Chiara Gnasso; Alberto Monello; Marco Manfrini; Arif Khokhar; Alessandro Sticchi; Andrea Biagi; Piergiorgio Turchio; Carlo Tacchetti; Giovanni Landoni; Edda Boccia; Gianluca Campo; Alessandra Scoccia; Francesco Ponticelli; Gian Battista Danzi; Marco Loffi; Margherita Muri; Gianluca Pontone; Daniele Andreini; Elisabetta Maria Mancini; Gianni Casella; Gianmarco Iannopollo; Tommaso Nannini; Davide Ippolito; Giacomo Bellani; Camillo Talei Franzesi; Gianluigi Patelli; Francesca Besana; Claudia Costa; Luigi Vignali; Giorgio Benatti; Nicola Sverzellati; Elisa Scarnecchia; Francesco Paolo Lombardo; Fabio Anastasio; Mario Iannaccone; Paolo Giacomo Vaudano; Alberto Pacielli; Lucio Baffoni; Iljia Gardi; Elisabetta Cesini; Massimiliano Sperandio; Chiara Micossi; Caterina Chiara De Carlini; Cristiano Spreafico; Stefano Maggiolini; Pietro Andrea Bonaffini; Attilio Iacovoni; Sandro Sironi; Michele Senni; Evgeny Fominskiy; Francesco De Cobelli; Aldo Pietro Maggioni; Claudio Rapezzi; Roberto Ferrari; Antonio Colombo; Antonio Esposito
Journal:  J Cardiovasc Comput Tomogr       Date:  2021-03-11

7.  Laboratory biomarkers of COVID-19 disease severity and outcome: Findings from a developing country.

Authors:  Tigist W Leulseged; Ishmael S Hassen; Birhanu T Ayele; Yakob G Tsegay; Daniel S Abebe; Mesay G Edo; Endalkachew H Maru; Wuletaw C Zewde; Lydia K Naylor; Dejene F Semane; Menayit T Dresse; Bereket B Tezera
Journal:  PLoS One       Date:  2021-03-15       Impact factor: 3.240

8.  The characteristics of laboratory tests at admission and the risk factors for adverse clinical outcomes of severe and critical COVID-19 patients.

Authors:  Liulin Wang; Xiaobin Cheng; Qiufen Dong; Chenliang Zhou; Yeming Wang; Bin Song; Weinan Li; Min Wang; Rui Qin; Qi Long; Juan Liu; Jing Li; Dan Li; Gang Li; Yuanming Ba
Journal:  BMC Infect Dis       Date:  2021-04-20       Impact factor: 3.090

9.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

10.  Coronary Artery Calcification and Complications in Patients With COVID-19.

Authors:  Jean Guillaume Dillinger; Fatima Azzahra Benmessaoud; Théo Pezel; Sebastian Voicu; Georgios Sideris; Naima Chergui; Lounis Hamzi; Anthony Chauvin; Pierre Leroy; Jean François Gautier; Damien Sène; Patrick Henry
Journal:  JACC Cardiovasc Imaging       Date:  2020-11
View more
  4 in total

1.  Lung Opacity and Coronary Artery Calcium Score: A Combined Tool for Risk Stratification and Outcome Prediction in COVID-19 Patients.

Authors:  Vitali Koch; Leon D Gruenewald; Moritz H Albrecht; Katrin Eichler; Tatjana Gruber-Rouh; Ibrahim Yel; Leona S Alizadeh; Scherwin Mahmoudi; Jan-Erik Scholtz; Simon S Martin; Lukas Lenga; Thomas J Vogl; Nour-Eldin A Nour-Eldin; Florian Bienenfeld; Renate M Hammerstingl; Christiana Graf; Christof M Sommer; Stefan E Hardt; Silvio Mazziotti; Giorgio Ascenti; Giovanni Antonio Versace; Tommaso D'Angelo; Christian Booz
Journal:  Acad Radiol       Date:  2022-02-28       Impact factor: 5.482

2.  How to deal with hypertension in the COVID-19 era-the impact "ON" and "OF" hypertension.

Authors:  Mari Ishida
Journal:  Hypertens Res       Date:  2021-12-17       Impact factor: 5.528

3.  Cardiomegaly found in hospitalized patients with novel coronavirus disease (COVID-19).

Authors:  Zeinab Shankayi; Farideh Bahrami; Tahereh Mohammadzadeh; Amineh Ghafari Anvar; Hosein Amini; M Mehdi Asadi; M Hassan Mirasheh; Mojtaba Sharti
Journal:  New Microbes New Infect       Date:  2022-03-15

Review 4.  Coronary artery calcium score as a prognostic factor of adverse outcomes in patients with COVID-19: a comprehensive review.

Authors:  Fateme Yousefimoghaddam; Ehsan Goudarzi; Alireza Ramandi; Isa Khaheshi
Journal:  Curr Probl Cardiol       Date:  2022-03-24       Impact factor: 16.464

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.